1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Fusion Biopsy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Fusion Biopsy Market, by Product Type
8.1.1. Equipment (Systems)
8.1.1.1. Market Revenue and Forecast
8.1.2. Software
8.1.2.1. Market Revenue and Forecast
8.1.3. Consumables & Accessories
8.1.3.1. Market Revenue and Forecast
9.1. Fusion Biopsy Market, by Biopsy Route
9.1.1. Transrectal (TRUS–MRI Fusion)
9.1.1.1. Market Revenue and Forecast
9.1.2. Transperineal (TP–MRI Fusion)
9.1.2.1. Market Revenue and Forecast
10.1. Fusion Biopsy Market, by Fusion Technique
10.1.1. Software-Based Fusion
10.1.1.1. Market Revenue and Forecast
10.1.2. Cognitive Fusion (Visual / Manual Estimation)
10.1.2.1. Market Revenue and Forecast
10.1.3. In-Bore MRI Fusion (Direct MRI-Guided Biopsy)
10.1.3.1. Market Revenue and Forecast
11.1. Fusion Biopsy Market, by Application
11.1.1. Prostate Cancer Diagnosis (Primary)
11.1.1.1. Market Revenue and Forecast
11.1.2. Renal (Kidney) Lesion Evaluation
11.1.2.1. Market Revenue and Forecast
11.1.3. Liver Tumor Targeting
11.1.3.1. Market Revenue and Forecast
11.1.4. Active Surveillance Monitoring
11.1.4.1. Market Revenue and Forecast
11.1.5. Focal Therapy Planning
11.1.5.1. Market Revenue and Forecast
12.1. Fusion Biopsy Market, by End-User
12.1.1. Hospitals & Tertiary Care Centers
12.1.1.1. Market Revenue and Forecast
12.1.2. Specialized Oncology Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Diagnostic Imaging Centers
12.1.3.1. Market Revenue and Forecast
12.1.4. Ambulatory Surgical Centers (ASCs)
12.1.4.1. Market Revenue and Forecast
12.1.5. Academic & Research Institutions
12.1.5.1. Market Revenue and Forecast
13.1. Fusion Biopsy Market, by Distribution Channel
13.1.1. Direct Sales (Institutional Procurement)
13.1.1.1. Market Revenue and Forecast
13.1.2. Indirect Sales (Medical Device Distributors)
13.1.2.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product Type
14.1.2. Market Revenue and Forecast, by Biopsy Route
14.1.3. Market Revenue and Forecast, by Fusion Technique
14.1.4. Market Revenue and Forecast, by Application
14.1.5. Market Revenue and Forecast, by End-User
14.1.6. Market Revenue and Forecast, by Distribution Channel
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Product Type
14.1.7.2. Market Revenue and Forecast, by Biopsy Route
14.1.7.3. Market Revenue and Forecast, by Fusion Technique
14.1.7.4. Market Revenue and Forecast, by Application
14.1.8. Market Revenue and Forecast, by End-User
14.1.8.1. Market Revenue and Forecast, by Distribution Channel
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product Type
14.1.9.2. Market Revenue and Forecast, by Biopsy Route
14.1.9.3. Market Revenue and Forecast, by Fusion Technique
14.1.9.4. Market Revenue and Forecast, by Application
14.1.10. Market Revenue and Forecast, by End-User
14.1.11. Market Revenue and Forecast, by Distribution Channel
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product Type
14.2.2. Market Revenue and Forecast, by Biopsy Route
14.2.3. Market Revenue and Forecast, by Fusion Technique
14.2.4. Market Revenue and Forecast, by Application
14.2.5. Market Revenue and Forecast, by End-User
14.2.6. Market Revenue and Forecast, by Distribution Channel
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product Type
14.2.8.2. Market Revenue and Forecast, by Biopsy Route
14.2.8.3. Market Revenue and Forecast, by Fusion Technique
14.2.9. Market Revenue and Forecast, by Application
14.2.10. Market Revenue and Forecast, by End-User
14.2.10.1. Market Revenue and Forecast, by Distribution Channel
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Product Type
14.2.11.2. Market Revenue and Forecast, by Biopsy Route
14.2.11.3. Market Revenue and Forecast, by Fusion Technique
14.2.12. Market Revenue and Forecast, by Application
14.2.13. Market Revenue and Forecast, by End-User
14.2.14. Market Revenue and Forecast, by Distribution Channel
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Product Type
14.2.15.2. Market Revenue and Forecast, by Biopsy Route
14.2.15.3. Market Revenue and Forecast, by Fusion Technique
14.2.15.4. Market Revenue and Forecast, by Application
14.2.16. Market Revenue and Forecast, by End-User
14.2.16.1. Market Revenue and Forecast, by Distribution Channel
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Product Type
14.2.17.2. Market Revenue and Forecast, by Biopsy Route
14.2.17.3. Market Revenue and Forecast, by Fusion Technique
14.2.17.4. Market Revenue and Forecast, by Application
14.2.18. Market Revenue and Forecast, by End-User
14.2.18.1. Market Revenue and Forecast, by Distribution Channel
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product Type
14.3.2. Market Revenue and Forecast, by Biopsy Route
14.3.3. Market Revenue and Forecast, by Fusion Technique
14.3.4. Market Revenue and Forecast, by Application
14.3.5. Market Revenue and Forecast, by End-User
14.3.6. Market Revenue and Forecast, by Distribution Channel
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Product Type
14.3.7.2. Market Revenue and Forecast, by Biopsy Route
14.3.7.3. Market Revenue and Forecast, by Fusion Technique
14.3.7.4. Market Revenue and Forecast, by Application
14.3.8. Market Revenue and Forecast, by End-User
14.3.9. Market Revenue and Forecast, by Distribution Channel
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Product Type
14.3.10.2. Market Revenue and Forecast, by Biopsy Route
14.3.10.3. Market Revenue and Forecast, by Fusion Technique
14.3.10.4. Market Revenue and Forecast, by Application
14.3.11. Market Revenue and Forecast, by End-User
14.3.11.1. Market Revenue and Forecast, by Distribution Channel
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Product Type
14.3.12.2. Market Revenue and Forecast, by Biopsy Route
14.3.12.3. Market Revenue and Forecast, by Fusion Technique
14.3.12.4. Market Revenue and Forecast, by Application
14.3.12.5. Market Revenue and Forecast, by End-User
14.3.12.6. Market Revenue and Forecast, by Distribution Channel
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Product Type
14.3.13.2. Market Revenue and Forecast, by Biopsy Route
14.3.13.3. Market Revenue and Forecast, by Fusion Technique
14.3.13.4. Market Revenue and Forecast, by Application
14.3.13.5. Market Revenue and Forecast, by End-User
14.3.13.6. Market Revenue and Forecast, by Distribution Channel
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product Type
14.4.2. Market Revenue and Forecast, by Biopsy Route
14.4.3. Market Revenue and Forecast, by Fusion Technique
14.4.4. Market Revenue and Forecast, by Application
14.4.5. Market Revenue and Forecast, by End-User
14.4.6. Market Revenue and Forecast, by Distribution Channel
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Product Type
14.4.7.2. Market Revenue and Forecast, by Biopsy Route
14.4.7.3. Market Revenue and Forecast, by Fusion Technique
14.4.7.4. Market Revenue and Forecast, by Application
14.4.8. Market Revenue and Forecast, by End-User
14.4.9. Market Revenue and Forecast, by Distribution Channel
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Product Type
14.4.10.2. Market Revenue and Forecast, by Biopsy Route
14.4.10.3. Market Revenue and Forecast, by Fusion Technique
14.4.10.4. Market Revenue and Forecast, by Application
14.4.11. Market Revenue and Forecast, by End-User
14.4.12. Market Revenue and Forecast, by Distribution Channel
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Product Type
14.4.13.2. Market Revenue and Forecast, by Biopsy Route
14.4.13.3. Market Revenue and Forecast, by Fusion Technique
14.4.13.4. Market Revenue and Forecast, by Application
14.4.13.5. Market Revenue and Forecast, by End-User
14.4.13.6. Market Revenue and Forecast, by Distribution Channel
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Product Type
14.4.14.2. Market Revenue and Forecast, by Biopsy Route
14.4.14.3. Market Revenue and Forecast, by Fusion Technique
14.4.14.4. Market Revenue and Forecast, by Application
14.4.14.5. Market Revenue and Forecast, by End-User
14.4.14.6. Market Revenue and Forecast, by Distribution Channel
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product Type
14.5.2. Market Revenue and Forecast, by Biopsy Route
14.5.3. Market Revenue and Forecast, by Fusion Technique
14.5.4. Market Revenue and Forecast, by Application
14.5.5. Market Revenue and Forecast, by End-User
14.5.6. Market Revenue and Forecast, by Distribution Channel
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Product Type
14.5.7.2. Market Revenue and Forecast, by Biopsy Route
14.5.7.3. Market Revenue and Forecast, by Fusion Technique
14.5.7.4. Market Revenue and Forecast, by Application
14.5.8. Market Revenue and Forecast, by End-User
14.5.8.1. Market Revenue and Forecast, by Distribution Channel
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product Type
14.5.9.2. Market Revenue and Forecast, by Biopsy Route
14.5.9.3. Market Revenue and Forecast, by Fusion Technique
14.5.9.4. Market Revenue and Forecast, by Application
14.5.9.5. Market Revenue and Forecast, by End-User
14.5.9.6. Market Revenue and Forecast, by Distribution Channel
15.1. Eigen
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Koninklijke Philips N.V.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Hitachi Ltd.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. MedCom
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. ESAOTE SPA
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. KOELIS
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Focal Healthcare
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. BK Medical Holding Company, Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Exact Imaging
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Biobot Surgical Pte Ltd.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client